With operations beginning in 2023 and the establishment of its global headquarters in Singapore in 2025, EDENA presents its ...
Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial. The biotech is planning to launch a late-stage program for the drug later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results